Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1

Conditions

Prostatic Neoplasms 8Glioblastoma 7Urinary Bladder Neoplasms 6Breast Neoplasms 6Oropharyngeal Neoplasms 5Neoplasm Metastasis 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Carcinoma 5Burkitt Lymphoma 5Astrocytoma 5Sarcoma 4Squamous Cell Carcinoma of Head and Neck 3Rhabdomyosarcoma, Embryonal 3Pancreatic Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Glioma 3Esophageal Neoplasms 3Adenocarcinoma of Lung 3Triple Negative Breast Neoplasms 2Sarcoma, Synovial 2Sarcoma, Ewing 2Rhabdomyosarcoma, Alveolar 2Rhabdomyosarcoma 2Rectal Neoplasms 2Prostate Adenocarcinoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Melanoma 2

Interventions

pembrolizumab 17Bevacizumab 12Standard of Care 10Cyclophosphamide 9Carboplatin 9Doxorubicin 7Cetuximab 7Nivolumab 6Exercise 6olaparib 5atezolizumab 5Rituximab 5Radiotherapy 5Pemetrexed 5Fluorouracil 5Cisplatin 5durvalumab 4dostarlimab 4abemaciclib 4Temozolomide 4Prednisone 4Paclitaxel 4Leucovorin 4Blood Specimen Collection 4venetoclax 3temsirolimus 3talazoparib 3pertuzumab 3obinutuzumab 3ibrutinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Radiation × 30 days × Clear all
NCT05427136 2026-05-08

SWISS-Pearl

University Children's Hospital Basel

Recruiting
140 enrolled
Tumor-Agnostic

Neoplasms

NCT01920932 2026-05-06

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
77 enrolled 20 charts
Lymphoid

Hodgkin Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡